Stabilizing action of disodium cromoglycate on erythrocyte membrane.

Publisher Website
Google Scholar
Abstract
The effect of disodium cromoglycate (DSCG) [an antiallergic drug used in asthma treatment] on hemolysis of rat erythrocytes was studied. The heat-induced hemolysis was remarkably inhibited by DSCG. This was not affected by normal rat serum and was maintained for longer than 60 min similar to the activity in clinical use, although the inhibitory effect of DSCG on reagin-induced histamine release from mast cell disappeared rapidly in 5 min after administration. Non-steroidal antiinflammatory drugs, such as flufenamic acid or phenylbutazone, which are known to inhibit the hemolysis depending on their protein stabilizing activities inhibited the heat-induced hemolysis and albumin denaturation, but DSCG did not inhibit the albumin denaturation. DSCG inhibited the hemolysis induced by lipophilic agents such as saponin linoleic acid or phospholipase C. DSCG has membrane stabilizing activity, in addition to the inhibitory effect on reagin-induced histamine release; the activity may be related to membrane lipids rather than membrane proteins.